Cy3 Goat Anti-Mouse IgG (H+L) Antibody: High-Sensitivity Fluorescent Detection

Executive Summary: The Cy3 Goat Anti-Mouse IgG (H+L) Antibody (K1207) is an affinity-purified, Cy3-conjugated secondary antibody that amplifies mouse IgG-based detection in immunofluorescence, flow cytometry, and immunohistochemistry. It is produced by immunizing goats with pooled mouse immunoglobulins and purified via immunoaffinity chromatography, resulting in high specificity and low background (APExBIO). The Cy3 fluorophore provides robust, photostable fluorescence for sensitive detection. This antibody is supplied at 1 mg/mL in PBS with stabilizers and preservatives, and is validated for enhanced signal amplification and reproducibility in translational research workflows (iScience 2024). Proper storage and handling ensure fluorescence integrity for up to 12 months at -20°C.

Biological Rationale

Secondary antibodies are essential for amplifying the detection signal of primary antibodies in immunoassays. The Cy3 Goat Anti-Mouse IgG (H+L) Antibody binds specifically to mouse immunoglobulins, enabling visualization and quantification of mouse-derived targets in complex biological samples. Mouse monoclonal and polyclonal antibodies are commonly used as primary reagents in biomedical research due to their diversity and specificity. The availability of a sensitive, species-specific secondary antibody ensures precise signal readout, particularly in applications such as immunofluorescence (IF), flow cytometry (FC), and immunohistochemistry (IHC) (Related Article). This antibody is particularly relevant for studies of tumor microenvironments, immune markers, and protein localization, as demonstrated in advanced cancer research (iScience 2024).

Mechanism of Action of Cy3 Goat Anti-Mouse IgG (H+L) Antibody

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is generated by immunizing goats with purified mouse IgG, followed by immunoaffinity purification. The antibody recognizes both heavy (H) and light (L) chains of mouse IgG, ensuring broad coverage of mouse IgG subclasses. The conjugation of the Cy3 fluorophore (excitation/emission: ~550/570 nm) enables direct fluorescent detection upon binding to the mouse primary antibody. Binding multiple secondary antibodies to a single primary antibody amplifies the detection signal, improving assay sensitivity and dynamic range (Contrast: extends by detailing Cy3-specific amplification advantages). Cy3 is selected for its high quantum yield, stability, and compatibility with standard fluorescence microscopes and flow cytometers. The antibody is supplied as a liquid (1 mg/mL) in PBS, 23% glycerol, 1% BSA, and 0.02% sodium azide, ensuring stability and minimizing background.

Evidence & Benchmarks

• Affinity purification reduces background and increases specificity in mouse IgG detection compared to crude antiserum (iScience 2024).
• Cy3 conjugation delivers superior photostability and bright fluorescence, enabling detection of low-abundance targets in immunofluorescence assays (Internal Benchmark).
• Signal amplification using Cy3 Goat Anti-Mouse IgG (H+L) Antibody increases detection sensitivity by up to 10-fold in flow cytometry relative to unconjugated or less-optimized secondary antibodies (Internal Evidence).
• Validated for use in immunofluorescence, flow cytometry, and IHC on tissue sections, with optimal results at 1–10 μg/mL working concentration (APExBIO Product Data).
• Stable for 12 months at -20°C with minimal loss of fluorescence when protected from light and freeze/thaw cycles (APExBIO).

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is suited for:

• Immunofluorescence imaging to localize mouse IgG targets in cells and tissues.
• Flow cytometry for quantitative analysis of mouse IgG-bound cellular markers.
• Immunohistochemistry for detecting mouse antibodies in formalin-fixed, paraffin-embedded (FFPE) or frozen tissue sections.
• Translational biomarker discovery, including studies on tumor microenvironment regulation (This article expands application guidance to tumor microenvironment mechanisms).

Common Pitfalls or Misconceptions

• Not suitable for direct detection of non-mouse primary antibodies (e.g., rabbit, rat).
• Cy3 fluorescence can be quenched by prolonged light exposure; always protect from light.
• Repeated freeze/thaw cycles reduce antibody performance; aliquot for long-term storage.
• Background may increase if blocking or washing is insufficient, especially in complex tissues.
• Does not distinguish between mouse IgG subclasses (IgG1, IgG2a, etc.)—binds all H+L chains.

Workflow Integration & Parameters

For optimal results, the antibody should be diluted in PBS with 1% BSA at a working concentration of 1–10 μg/mL, depending on assay sensitivity requirements. Incubate with the sample for 30–60 minutes at room temperature, protected from light. Wash thoroughly to remove unbound antibody. Imaging or analysis should be performed using instruments equipped with a Cy3-appropriate filter set (excitation 550 nm, emission 570 nm). The product is shipped at 4°C and should be stored at 4°C for up to 2 weeks or aliquoted and stored at -20°C for up to 12 months. Avoid repeated freeze/thaw cycles. Refer to the product page for lot-specific protocols and troubleshooting.

Conclusion & Outlook

The Cy3 Goat Anti-Mouse IgG (H+L) Antibody (K1207) from APExBIO is a rigorously validated, high-sensitivity secondary reagent for fluorescence-based detection of mouse IgG. Its robust signal amplification, specificity, and compatibility with key immunoassay platforms make it a critical tool in both discovery and translational research. As immunofluorescence and flow cytometry workflows increasingly underpin biomarker and mechanistic studies—such as those dissecting the tumor microenvironment and drug resistance pathways (iScience 2024)—the demand for reproducible, sensitive secondary antibodies will continue to grow. This article clarifies technical boundaries and expands upon prior internal guides by providing a comprehensive, evidence-based overview of the Cy3 Goat Anti-Mouse IgG (H+L) Antibody's capabilities and limitations for the advanced practitioner.